Modifying Diet to Improve Gut Microbiome

ConditionObesity
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorH. Lee Moffitt Cancer Center and Research Institute

About this trial

The investigators will conduct a 2-arm randomized controlled pilot, feasibility feeding study in which 28 participants will be randomized to receive either a calorie-restricted Dietary Approaches to Stop Hypertension (DASH) diet or a calorie-restricted standard American diet provided by the study for 4 weeks. Participants will be non-Hispanic black or white, generally healthy females (14 black, 14 white). The investigators will collect fecal samples at multiple time points before, during, and after the dietary intervention to analyze for changes in the gut microbiota and functional-level metabolic products. This work will be led by an interdisciplinary team including expertise in bio-behavioral science, microbiology, nutrition science, bioinformatics, and biostatistics all with cross-cutting expertise in health disparities, prevention research, nutrition, the gut microbiota, inflammation and other biomarkers. The rationale for the proposed research is that once the interactions between race, diet, and the gut microbiota are more fully understood, targeted diet modifications may provide new and innovative approaches for the prevention and treatment of obesity and obesity-related diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

female

non-Hispanic, black or white

age 19-65 years

BMI >= 30 kg/m²

Disqualifiers

gastrointestinal (GI) conditions i.e., irritable bowel, diverticulitis, peptic ulcers, Crohn's, GI cancers, and adenatomous polyps

antibiotic or probiotic use in the previous 90 days

tobacco use

heavy alcohol consumption

Trial design

Design model

Parallel

Treatments tested in this trial

  • DASH diet

    Behavioral

    brief description

  • standard American diet

    Behavioral

    describe

Treatment groups

28 Participants
are divided into 2 treatment groups
Group A: DASH dietExperimental treatment 1 intervention
Group B: standard American dietActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Mean Weight Change of Participants

Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged.

Time frame
Baseline to day 28
2

Mean Weight Change of Participants

Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged.

Time frame
Day 28 to Day 42
3

Mean Weight Change of Participants

Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged.

Time frame
Baseline to day 42
4

Diet-specific changes in secondary bile acid

The investigators will calculate changes in cholic acid in milligrams.

Time frame
Baseline to day 28

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: